Company Filing History:
2 out of 97 
1 out of 23 
1 out of 1 Years Active: 2003-2009
Title: Mark A Smith: Innovator in Pharmaceutical Compounds
Introduction
Mark A Smith is a notable inventor based in Landenberg, Pennsylvania. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target neurotransmitter availability. With a total of four patents to his name, Smith's work has the potential to impact the treatment of various disorders.
Latest Patents
Smith's latest patents include innovative compounds such as aryl and heteroaryl substituted tetrahydroisoquinolines. These compounds are designed to address disorders that arise from decreased availability of serotonin, norepinephrine, or dopamine. The specific formulae provided in his patents detail the structural components of these compounds, emphasizing their therapeutic potential.
Career Highlights
Throughout his career, Mark A Smith has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Albany Molecular Research, Inc. and Amr Technology, Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Smith has collaborated with several professionals in his field, including colleagues such as James Beck and Matt A Curry. These collaborations have likely enhanced his research and development efforts, leading to the successful creation of his patented compounds.
Conclusion
Mark A Smith's contributions to pharmaceutical innovations demonstrate his commitment to improving treatment options for disorders related to neurotransmitter imbalances. His patents reflect a deep understanding of medicinal chemistry and a dedication to advancing healthcare solutions.